Chia‐Chi Lin
Impact in
- Oncology top 2%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment
Papers in
- Oncology 75
- Cancer Immunotherapy and Biomarkers 26
- Lung Cancer Research Studies 21
- Colorectal Cancer Treatments and Studies 18
-
- Lung Cancer Treatments and Mutations 42
- Gastric Cancer Management and Outcomes 10
- Co-authors
- James Chih‐Hsin Yang (31 shared papers)Jih‐Hsiang Lee (15 shared papers)Bin-Chi Liao (12 shared papers)Chih‐Hung Hsu (22 shared papers)Ann‐Lii Cheng (15 shared papers)Jin‐Yuan Shih (9 shared papers)Chong‐Jen Yu (9 shared papers)Chao‐Chi Ho (8 shared papers)
- Journals
- Journal of Clinical Oncology (27 papers)Cancer Research (10 papers)Journal of Thoracic Oncology (6 papers)Molecular Cancer Therapeutics (4 papers)Investigational New Drugs (4 papers)
- Partner nations
- TaiwanUnited StatesSouth Korea
In The Last Decade
Chia‐Chi Lin
111 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 112
- Oncology 1.3k
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 324
- Immunology 267
- Hepatology 83
Countries citing papers authored by Chia‐Chi Lin
This map shows the geographic impact of Chia‐Chi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chia‐Chi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chia‐Chi Lin more than expected).
Fields of papers citing papers by Chia‐Chi Lin
This network shows the impact of papers produced by Chia‐Chi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chia‐Chi Lin. The network helps show where Chia‐Chi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chia‐Chi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 248 | |
| 2 | 2015 | 138 | |
| 3 | 2017 | 117 | |
| 4 | 2006 | 107 | |
| 5 | 2019 | 64 | |
| 6 | 2020 | 63 | |
| 7 | 2011 | 53 | |
| 8 | 2019 | 52 | |
| 9 | 2021 | 50 | |
| 10 | 2018 | 44 | |
| 11 | 2013 | 44 | |
| 12 | 2021 | 41 | |
| 13 | 2016 | 41 | |
| 14 | 2017 | 38 | |
| 15 | 2016 | 37 | |
| 16 | 2018 | 37 | |
| 17 | 2014 | 36 | |
| 18 | 2020 | 36 | |
| 19 | 2011 | 34 | |
| 20 | 2009 | 32 |
About Chia‐Chi Lin
Chia‐Chi Lin is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Cancer Research, having authored 115 papers that have together received 2.3k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (42 papers), Cancer Immunotherapy and Biomarkers (26 papers), Lung Cancer Research Studies (21 papers), Colorectal Cancer Treatments and Studies (18 papers), Esophageal Cancer Research and Treatment (16 papers), Cancer Genomics and Diagnostics (15 papers), Cancer therapeutics and mechanisms (12 papers) and Gastric Cancer Management and Outcomes (10 papers). The work is most often cited by research in Oncology (1.3k citations), Pulmonary and Respiratory Medicine (1.3k citations), Cancer Research (324 citations), Immunology (267 citations) and Hepatology (83 citations). Chia‐Chi Lin has collaborated with scholars based in Taiwan, United States and South Korea. Frequent co-authors include James Chih‐Hsin Yang, Jih‐Hsiang Lee, Bin-Chi Liao, Chih‐Hung Hsu, Ann‐Lii Cheng, Jin‐Yuan Shih, Chong‐Jen Yu, Chao‐Chi Ho, Todd M. Bauer and Benjamin Solomon. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Thoracic Oncology, Molecular Cancer Therapeutics and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.